Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001235802-09-000119
Filing Date
2009-10-15
Accepted
2009-10-15 18:59:57
Documents
1
Period of Report
2009-10-14

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 5800
  Complete submission text file 0001235802-09-000119.txt   7705
Mailing Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069 8474780500
BIOSANTE PHARMACEUTICALS INC (Issuer) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O CELL GENESYS, INC. 500 FORBES BLVD. S. SAN FRANCISCO CA 94080
Business Address
POTTS JOHN T JR (Reporting) CIK: 0001202447 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31812 | Film No.: 091122212